Addex Therapeutics to Release Q1 2024 Financial Results and

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...

Related Keywords

Geneva , Genè , Switzerland , United States , American , Swiss , Mikhail Kalinichev , Mike Sinclair , Tim Dyer , Swiss Exchange , Janssen Pharmaceuticals Inc , Nasdaq , Translational Science , Addex Therapeutics , Conference Call , Participant Dial In , American Depositary Shares ,